# Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer

> **NCT05742256** · PHASE1 · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 159 (estimated)

## Conditions studied

- Oxycodone

## Interventions

- **DRUG:** Oxycodone 1mg/kg
- **DRUG:** Oxycodone 1.5mg/kg
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT05742256
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05742256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05742256, "Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05742256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*